Alzheimer’s disease Archives
Vanderbilt Kennedy Center to host Jan. 25 workshop on Down syndrome and Alzheimer’s disease
Jan. 5, 2022—The Vanderbilt Kennedy Center is teaming up with the Down Syndrome Association of Middle Tennessee to host a virtual workshop on “Risks of Alzheimer’s Disease in Adults with Down Syndrome and Introduction to a Research Study.” The discussion will take place Tuesday, Jan. 25, from 2-3 p.m. CST. Click here to register Down syndrome, or...
“Supermeres” may carry clues to cancer, Alzheimer’s disease and COVID-19
Dec. 10, 2021—Vanderbilt researchers have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19.
Vanderbilt voices featured in Alzheimer’s webcast
Nov. 19, 2021—Vanderbilt researchers took part in an online panel discussion this week sponsored by the Women’s Alzheimer’s Movement (WAM), hosted by journalist and author Maria Shriver, the organization’s founder, and NBC news anchor Richard Lui.
VUMC awarded $31.7 million to harmonize Alzheimer’s research data
Oct. 1, 2021—Vanderbilt University Medical Center has received a $31.7 million federal grant to harmonize research data gathered on human subjects in scores of disparate studies of Alzheimer’s disease and related dementias.
Project seeks to treat Alzheimer’s in people with Down syndrome
Sep. 30, 2021—A joint project between the Vanderbilt Kennedy Center and the Vanderbilt Center for Cognitive Medicine will help deliver Alzheimer’s disease therapies and treatments to people with Down syndrome (DS).
Arterial stiffening linked to Alzheimer’s disease
Jul. 15, 2021—A research team from Vanderbilt University Medical Center reports in Neurology that greater stiffening of the aorta, the main artery in the human body, is associated in older adults with increased Alzheimer’s disease (AD) pathology as reflected in a range of neurochemical indicators measured in cerebrospinal fluid.
Alzheimer’s study tracks protein located inside cells
Apr. 15, 2021—New research from Vanderbilt University Medical Center, published recently in the journal PLOS Genetics, suggests an essential role for a somewhat obscure biomolecule and casts light on a potential drug target in Alzheimer’s disease.
Chemo for cancer lowers dementia risk
Mar. 22, 2021—Cancer chemotherapy lowered risk of Alzheimer’s disease and other neurocognitive disorders that disproportionately affect older people.
Imaging “biomarker” for Alzheimer’s disease progression
Nov. 16, 2020—Changes in connectivity in the brain’s white matter may be a novel neuroimaging biomarker for assessing Alzheimer’s disease progression.
VUMC forms center focused on Alzheimer’s and related dementias
Oct. 1, 2020—Leaders at Vanderbilt University Medical Center have announced that the Vanderbilt Memory and Alzheimer’s Center (VMAC), currently housed in the Department of Neurology, will become a freestanding institutional center.
VUMC to lay groundwork for Tennessee’s first federally funded Alzheimer’s Disease Research Center
Sep. 10, 2020—Angela Jefferson, PhD, professor of Neurology and director of the Vanderbilt Memory and Alzheimer’s Center, has been awarded a $3.7 million, three-year grant from the National Institute on Aging (NIA) to support establishment of a prospective NIA-funded Alzheimer’s Disease Research Center (ADRC) at Vanderbilt University Medical Center.
New clue to Alzheimer’s disease
Sep. 3, 2020—Combining studies of genetically diverse mouse populations and human data led to the identification of a gene associated with cognitive decline and brain changes in Alzheimer’s disease.
